When ACTC board of directors member, former FDA high-ranking scientist, and award-wining Dr. Langer buys his first few shares of actc on the open market, that should be your buy signal. Unlike Lanza and Rabin, Langer DOES NOT receive millions and millions of free shares courtesy of the bag holders. No reason on earth for him not to invest in actc, today, unless,,,,,,,,
Karen, what you say makes no sense, because ACT is still in startup mode, essenially have no revenues. Therefore the company sold stock to finance the business and pay their employee's. And guys like Lanza, Rabin, and etc, were paid piddling in cash for years, now the company is paying them a decent wage, but they could make far more, especially Lanza, if they went somewhere else, besides they already have tons of stock, so why buy more?
You just made the case for actc. If Lanza doesn't buy or recieve shares, and hes' so good, why does he stick around, especially if he could write his own ticket someplace else? Maybe partly because he's got a lot of time and effort put into this company, but he also must believe, imo.